{"disease":{"id":"nausea","name":"nausea","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":10},"drugs":{"marketed":[{"drug_id":"ether","indication_name":"Relief of nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ETHER","company_name":"","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"nabilone","indication_name":"Nausea and Vomiting from Chemotherapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cesamet","generic_name":"NABILONE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Cannabinoid receptor 1","drug_class":"Cannabinoid [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"sodium-sulfate","indication_name":"Headache pain with nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SODIUM SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"dronabinol","indication_name":"Nausea and vomiting with cancer chemotherapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Marinol","generic_name":"DRONABINOL","company_name":"Wellhouse Pharma","drug_phase":"marketed","molecular_target":"Cannabinoid receptors","drug_class":"Cannabinoid [EPC]","quality_score":80,"revenue":null,"mechanism":"Dronabinol acts on cannabinoid receptors in the CNS, potentially through central sympathomimetic activity."},{"drug_id":"prochlorperazine-maleate","indication_name":"Severe Nausea and Vomiting Control","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROCHLORPERAZINE MALEATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"chlorpromazine","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Thorazine","generic_name":"chlorpromazine","company_name":"Generic (originally Rhône-Poulenc/Sanofi)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Sphingomyelin phosphodiesterase, 5-hydroxytryptamine receptor 1E","drug_class":"Typical antipsychotic (first-generation, phenothiazine)","quality_score":31,"revenue":null,"mechanism":""},{"drug_id":"metaclopramide","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metaclopramide","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"metaclopramide","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metaclopramide","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"droleptan","indication_name":"Intra-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Droleptan","company_name":"Clinique Saint Jean, France","drug_phase":"phase_1","molecular_target":"D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"droleptan","indication_name":"Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Droleptan","company_name":"Clinique Saint Jean, France","drug_phase":"phase_1","molecular_target":"D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"ozone","indication_name":"nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pollutox","generic_name":"OZONE","company_name":"Deseret Biologicals, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Radiographic Contrast Agent [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"netupitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akynzeo","generic_name":"NETUPITANT","company_name":"Helsinn Hlthcare","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Serotonin-3 Receptor Antagonist [EPC]","quality_score":57,"revenue":null,"mechanism":"Akynzeo works by blocking the substance P/neurokinin-1 receptor to prevent nausea and vomiting caused by chemotherapy."},{"drug_id":"aprepitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emend","generic_name":"APREPITANT","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist [EPC]","quality_score":62,"revenue":null,"mechanism":"Emend works by blocking the action of a natural substance called substance P, which is involved in the vomiting reflex."},{"drug_id":"aprepitant","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emend","generic_name":"APREPITANT","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist [EPC]","quality_score":62,"revenue":null,"mechanism":"Emend works by blocking the action of a natural substance called substance P, which is involved in the vomiting reflex."},{"drug_id":"amisulpride","indication_name":"Postoperative nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Barhemsys","generic_name":"AMISULPRIDE","company_name":"Acacia","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist [EPC]","quality_score":57,"revenue":null,"mechanism":"Barhemsys works by blocking dopamine receptors in the brain."},{"drug_id":"metoclopramide","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"METOCLOPRAMIDE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"METOCLOPRAMIDE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide-hydrochloride","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"Metoclopramide Hydrochloride","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Acetylcholine receptor sensitization; dopamine antagonism (implied)","drug_class":"Prokinetic agent","quality_score":10,"revenue":null,"mechanism":"Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action."},{"drug_id":"metoclopramide-hydrochloride","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"Metoclopramide Hydrochloride","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Acetylcholine receptor sensitization; dopamine antagonism (implied)","drug_class":"Prokinetic agent","quality_score":10,"revenue":null,"mechanism":"Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action."},{"drug_id":"fosnetupitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akynzeo","generic_name":"FOSNETUPITANT","company_name":"Helsinn Hlthcare","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Serotonin-3 Receptor Antagonist [EPC]","quality_score":48,"revenue":null,"mechanism":"Akynzeo works by blocking the action of substance-P, a natural substance in the body that triggers nausea and vomiting."},{"drug_id":"cinnarizine","indication_name":"Nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cinarizine","generic_name":"CINNARIZINE","company_name":"","drug_phase":"phase_2","molecular_target":"Histamine H1 receptor","drug_class":"cinnarizine","quality_score":null,"revenue":null,"mechanism":"Cinarizine works by blocking histamine receptors in the brain, which helps to reduce symptoms of motion sickness and vertigo."},{"drug_id":"alizapride","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALIZAPRIDE","company_name":"","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"alizapride","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"alizapride","indication_name":"Postoperative nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALIZAPRIDE","company_name":"","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"alizapride","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tropisetron","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Navoban","generic_name":"TROPISETRON","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"tropisetron","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"motilium","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Motilium","company_name":"Rabin Medical Center","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"dimenhydrinate","indication_name":"Nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dimenhydrinate","generic_name":"DIMENHYDRINATE","company_name":"Alra","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"dimenhydrinate","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dimenhydrinate","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dimenhydrinate","generic_name":"DIMENHYDRINATE","company_name":"Alra","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"dimenhydrinate","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dimenhydrinate","indication_name":"Prevention of Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dimenhydrinate","generic_name":"DIMENHYDRINATE","company_name":"Alra","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"dimenhydrinate","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"marinol","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Marinol","company_name":"Jazz Pharmaceuticals","drug_phase":"marketed","molecular_target":"N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"estrone","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"estrone","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"estrone","indication_name":"Prevention of Radiation-Induced Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"thiethylperazine","indication_name":"Nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ethylthioperazine","generic_name":"THIETHYLPERAZINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"thiethylperazine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"thiethylperazine","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ethylthioperazine","generic_name":"THIETHYLPERAZINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"thiethylperazine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"gran","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GRAN®","company_name":"EVIVE Biotechnology","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"gran","indication_name":"Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GRAN®","company_name":"EVIVE Biotechnology","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"gran","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GRAN®","company_name":"EVIVE Biotechnology","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"gran","indication_name":"Prevention of Radiation-Induced Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GRAN®","company_name":"EVIVE Biotechnology","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"nabilone","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cesamet","generic_name":"NABILONE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Cannabinoid receptor 1","drug_class":"Cannabinoid [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"triflupromazine","indication_name":"Nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Psyquil","generic_name":"TRIFLUPROMAZINE","company_name":"","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, 5-hydroxytryptamine receptor 2A, D(2) dopamine receptor","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"triflupromazine","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Psyquil","generic_name":"TRIFLUPROMAZINE","company_name":"","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, 5-hydroxytryptamine receptor 2A, D(2) dopamine receptor","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"scopolamine","indication_name":"Postoperative nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SCOPOLAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptors","drug_class":"Anticholinergic [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"promethazine","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenergan","generic_name":"promethazine","company_name":"Generic (originally Wyeth/Pfizer)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 6, FAD-linked sulfhydryl oxidase ALR","drug_class":"Phenothiazine antihistamine/antiemetic","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"fosaprepitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emend","generic_name":"FOSAPREPITANT","company_name":"","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist","quality_score":75,"revenue":null,"mechanism":"Emend blocks the action of substance P, a natural substance that can trigger nausea and vomiting."},{"drug_id":"dolasetron","indication_name":"Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anzemet","generic_name":"DOLASETRON","company_name":"Validus Pharms","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"Serotonin-3 Receptor Antagonist","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"dolasetron","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anzemet","generic_name":"DOLASETRON","company_name":"Validus Pharms","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"Serotonin-3 Receptor Antagonist","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"droperidol","indication_name":"Intra-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inapsine","generic_name":"DROPERIDOL","company_name":"Rising","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"droperidol","indication_name":"Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inapsine","generic_name":"DROPERIDOL","company_name":"Rising","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"perphenazine","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trilafon","generic_name":"PERPHENAZINE","company_name":"","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Phenothiazine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prochlorperazine","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Compazine","generic_name":"PROCHLORPERAZINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Phenothiazine","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"prochlorperazine","indication_name":"Prolonged-Severe Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Compazine","generic_name":"PROCHLORPERAZINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Phenothiazine","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"rolapitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Varubi","generic_name":"ROLAPITANT","company_name":"Tersera","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist","quality_score":65,"revenue":null,"mechanism":"Varubi works by blocking the substance-P receptor, a key player in the body's response to chemotherapy-induced nausea and vomiting."},{"drug_id":"maltodextrin","indication_name":"nausea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aspartame/MSG Detox","generic_name":"MALTODEXTRIN","company_name":"Deseret Biologicals, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"benzquinamide","indication_name":"Postoperative nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emeticon","generic_name":"BENZQUINAMIDE","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"benzquinamide","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"dronabinol","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Marinol","generic_name":"DRONABINOL","company_name":"Wellhouse Pharma","drug_phase":"marketed","molecular_target":"Cannabinoid receptors","drug_class":"Cannabinoid [EPC]","quality_score":80,"revenue":null,"mechanism":"Dronabinol acts on cannabinoid receptors in the CNS, potentially through central sympathomimetic activity."},{"drug_id":"domperidone","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Motilium","generic_name":"domperidone","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2","drug_class":"Prokinetic agent / Antiemetic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"domperidon","indication_name":"Nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Domperidon","company_name":"Gadjah Mada University","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cesamet","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cesamet","company_name":"Veeda Oncology","drug_phase":"marketed","molecular_target":"Cannabinoid receptor 2, Cannabinoid receptor 1, Cannabinoid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"tetrahydrocannabinol","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"tetrahydrocannabinol","company_name":"Wageningen University","drug_phase":"marketed","molecular_target":"N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"scopolamin","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"scopolamin","company_name":"University Hospital, Angers","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ondansetron","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zofran","generic_name":"ondansetron","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1","drug_class":"5-HT3 receptor antagonist (antiemetic)","quality_score":null,"revenue":null,"mechanism":"Selective 5-HT3 receptor antagonist that blocks serotonin-mediated nausea and vomiting signals in the CTZ and vagal afferents."},{"drug_id":"ondansetron","indication_name":"Prevention of Post-Operative Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zofran","generic_name":"ondansetron","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1","drug_class":"5-HT3 receptor antagonist (antiemetic)","quality_score":null,"revenue":null,"mechanism":"Selective 5-HT3 receptor antagonist that blocks serotonin-mediated nausea and vomiting signals in the CTZ and vagal afferents."},{"drug_id":"ondansetron","indication_name":"Prevention of Radiation-Induced Nausea and Vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zofran","generic_name":"ondansetron","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1","drug_class":"5-HT3 receptor antagonist (antiemetic)","quality_score":null,"revenue":null,"mechanism":"Selective 5-HT3 receptor antagonist that blocks serotonin-mediated nausea and vomiting signals in the CTZ and vagal afferents."}],"pipeline":[],"offLabel":[],"totalMarketed":63,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04433676","title":"Early PONV - a Registry Based Study in Sweden.","phase":"","overall_status":"UNKNOWN","enrollment_count":1500000,"lead_sponsor_name":"Jakob Wallden","has_results":false},{"nct_id":"NCT05765162","title":"Safe Brain Initiative, Operationalizing Precision Anaesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT06816355","title":"Exogenous Sex Hormones and PONV","phase":"","overall_status":"COMPLETED","enrollment_count":7348,"lead_sponsor_name":"Riverside University Health System Medical Center","has_results":false},{"nct_id":"NCT07403370","title":"Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Shandong Cancer Hospital and Institute","has_results":false},{"nct_id":"NCT04726254","title":"The JULI Registry--Hemp and Cannabis Observational Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Juva Life","has_results":false},{"nct_id":"NCT04043247","title":"Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting","phase":"NA","overall_status":"COMPLETED","enrollment_count":1655,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06226922","title":"Risk Factors for Postoperative Nausea and Vomiting in Surgical Patients Undergoing Patient-controlled Intravenous Analgesia.","phase":"","overall_status":"COMPLETED","enrollment_count":1371,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06886451","title":"Vomiting Prevention in Children With Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":1332,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT03019341","title":"Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media","phase":"","overall_status":"COMPLETED","enrollment_count":1175,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06443697","title":"A Machine Learning Prediction Model for Delayed CIPONV","phase":"","overall_status":"COMPLETED","enrollment_count":1154,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT06445920","title":"Risk Factors Analysis for Clinical Important Postoperative Nausea and Vomiting","phase":"","overall_status":"COMPLETED","enrollment_count":1154,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05690802","title":"The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV","phase":"NA","overall_status":"RECRUITING","enrollment_count":1060,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT01594749","title":"Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1015,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03795766","title":"Nausea and Vomiting After Gynecologic Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07488468","title":"Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT03740672","title":"Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04719741","title":"Drug and Dose Adjustment in Preventing Postoperative Nausea and Vomiting","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Jordan Hospital","has_results":false},{"nct_id":"NCT00090246","title":"2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":922,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT07244575","title":"Association Between Preoperative Metformin Exposure and Postoperative Nausea and Vomiting in Patients Undergoing General Anesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":909,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT03601871","title":"The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":880,"lead_sponsor_name":"Yunpeng Liu","has_results":false},{"nct_id":"NCT00092183","title":"An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":866,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00337727","title":"Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":848,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00092196","title":"Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":820,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00431236","title":"A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":810,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00090155","title":"2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":805,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03641625","title":"Effect of SmtO2 Guided Care on PONV (iMODIPONV)","phase":"NA","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT05509634","title":"Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":754,"lead_sponsor_name":"Fujian Shengdi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT00601172","title":"A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":710,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06554184","title":"HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":706,"lead_sponsor_name":"Fujian Shengdi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05970055","title":"Prevalence and Associated Factors of Post-operative Nausea and Vomiting","phase":"","overall_status":"COMPLETED","enrollment_count":677,"lead_sponsor_name":"Sara Timerga","has_results":false},{"nct_id":"NCT07081256","title":"To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05757986","title":"Predictive Model for PONV for Patient Received Gynecological Laparoscopic Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":659,"lead_sponsor_name":"Jiang Liu","has_results":false},{"nct_id":"NCT06331520","title":"NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04654429","title":"Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients?","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":628,"lead_sponsor_name":"Dr Lim Siu Min","has_results":false},{"nct_id":"NCT05838638","title":"Serious Gaming for Chemotherapy-induced Nausea and Vomiting","phase":"NA","overall_status":"RECRUITING","enrollment_count":610,"lead_sponsor_name":"University of Central Florida","has_results":false},{"nct_id":"NCT02530216","title":"Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT07238179","title":"Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT05830279","title":"Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT03645239","title":"Post-operative Emesis and Pain Outcomes After Cesarean Delivery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":595,"lead_sponsor_name":"KK Women's and Children's Hospital","has_results":false},{"nct_id":"NCT06981754","title":"Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":588,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT02400047","title":"Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04437017","title":"Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":557,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04861337","title":"Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":552,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT04188431","title":"Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":523,"lead_sponsor_name":"Walid HABRE","has_results":false},{"nct_id":"NCT06932107","title":"Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":518,"lead_sponsor_name":"Qilu Pharmaceutical (Hainan) Co., Ltd.","has_results":false},{"nct_id":"NCT06988124","title":"Dexamethasone Palmitate for PONV After Craniotomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06997419","title":"Dexamethasone Palmitate for PONV After Open Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06756022","title":"Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Anhui Provincial Children's Hospital","has_results":false},{"nct_id":"NCT01636947","title":"A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":494,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06543966","title":"Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":486,"lead_sponsor_name":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}